News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.
Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...
Interesting Engineering on MSN
US designs carbon-negative enzyme-based building material to replace concrete
US team has developed Enzymatic Structural Material, a carbon-negative alternative to concrete that turns CO2 into a ...
Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...
Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced the submission of a Biologics License ...
Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...
Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride ...
Stacker on MSN
Top science stories of 2025
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary hearing loss and neurological disease. Researchers at the Department of Cell and ...
A group of Iranian scientists from the National Institute of Genetic Engineering and Biotechnology claimed that they have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback